Evergreen Talk Series: Use of SGLT2i and DPP4i combination in T2DM patients with a history of Genitourinary Tract Infections MD Brand Connect1 Feb 2024 10:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
CDSCO Panel Grants Novartis Protocol Amendment Proposal For anti-cholesterol drug Inclisiran Dr. Divya Colin28 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Evergreen Talk Series: Position paper published in JAPI indicated that Linagliptin is simplifying T2DM management in a Wide Range of Patients MDTV Bureau23 Jan 2024 11:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Evergreen Talk Series: Clinical Considerations for Linagliptin and its combinations with Metformin, Dapagliflozin MD Brand Connect2 Jan 2024 11:00 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Extended use of inclisiran safe and efficacious among refractory dyslipidemia in patients with increased CV risk Dr Riya Dave29 Dec 2023 8:45 PM ISTA recent study sheds light on the safety profile of inclisiran, an innovative agent designed to reduce low-density lipoprotein cholesterol (LDL-C)....
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
Eating meals early could reduce cardiovascular risk Anshika Mishra16 Dec 2023 9:15 AM ISTCardiovascular diseases are the leading cause of death in the world according to the Global Burden of Disease study, with 18.6 million annual deaths...
Tomatoes in diet may reduce hypertension and cardiovascular disease risk Niveditha Subramani1 Dec 2023 12:00 PM ISTTomatoes is an important ingredient in most foods and salads, its the major dietary source of the antioxidant lycopene, which has been linked to many...
Evergreen Talk Series: Clinical applicability of Linagliptin in T2DM across CKD spectrum and Dapagliflozin up to CKD stage 4 MD Brand Connect1 Dec 2023 11:17 AM IST Advertisement Presenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and...
Allergic responses to common foods could increase risk of heart disease, cardiovascular death Preksha garg29 Nov 2023 11:30 AM ISTAllergic responses to common foods such as dairy and peanuts can increase the risk for heart disease and cardiovascular death as much or more than...
Increasing workplace flexibility associated with lower risk of cardiovascular disease Isra Zaman11 Nov 2023 9:15 AM ISTIncreasing workplace flexibility may lower employees' risk of cardiovascular disease, according to a new study led by Harvard T.H. Chan School of...
Evergreen Talk Series: Clinical Benefits of Linagliptin and Dapagliflozin Combination in Type 2 Diabetes Management MD Brand Connect10 Nov 2023 11:54 AM IST Advertisement Presenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a...
